Evidence map›Paper›PMID 17442486›Full record

ArticleNeuroscience letters2007

Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.

P J S Vig, J Wei, Q Shao, M D Hebert, S H Subramony, L T Sutton

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Pathogenic mechanisms underlying spinocerebellar ataxia type 1.Cellular and molecular life sciences : CMLS · 2020
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

P J S VigDepartment of Neurology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA. pvig@neurology.umsmed.edu
J Wei
Q Shao
M D Hebert
S H Subramony
L T Sutton
University of Mississippi Medical Center · USState Street (United States) · US

Funding

Mechanisms of Ataxin-1 Mediated Purkinje Cell DeathR01NS041546 · NINDS · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI VIG, PARMINDER J · 2003 to 2007
$783k
NINDS NIH HHS R01 NS041546
6 · The paper itself

Abstract

Spinocerebellar ataxia-1 (SCA1) is caused by the expansion of a polyglutamine repeats within the disease protein, ataxin-1. The mutant ataxin-1 precipitates as large intranuclear aggregates in the affected neurons. These aggregates may protect neurons from mutant protein and/or trigger neuronal degeneration by encouraging recruitment of other essential proteins. Our previous studies have shown that calcium binding protein calbindin-D28k (CaB) associated with SCAl pathogenesis is recruited to ataxin-l aggregates in Purkinje cells of SCAl mice. Since our recent findings suggest that tissue transglutaminase 2 (TG2) may be involved in crosslinking and aggregation of ataxin-l, the present study was initiated to determine if TG2 has any role in CaB-ataxin-l interaction. The guinea pig TG2 covalently crosslinked purified rat brain CaB. Time dependent progressive increase in aggregation produced large multimers, which stayed on top of the gel. CaB interaction with ataxin-l was studied using HeLa cell lysates expressing GFP and GFP tagged ataxin-l with normal and expanded polyglutamine repeats (Q2, Q30 and Q82). The reaction products were analyzed by Western blots using anti-polyglutamine, CaB or GFP antibodies. CaB interacted with ataxin-1 independent of TG2 as the protein-protein crosslinker DSS stabilized CaB-ataxin-l complex. TG2 crosslinked CaB preferentially with Q82 ataxin-1. The crosslinking was inhibited with EGTA or TG2 inhibitor cystamine. The present data indicate that CaB may be a TG2 substrate. In addition, aggregates of mutant ataxin-l may recruit CaB via TG2 mediated covalent crosslinking, further supporting the argument that ataxin-l aggregates may be toxic to neurons.

Indexed as

AnimalsAtaxin-1AtaxinsBlotting, WesternCalbindin 1CalbindinsCell NucleusCerebellumCross-Linking ReagentsElectrophoresis, Polyacrylamide GelGreen Fluorescent ProteinsGTP-Binding ProteinsHeLa CellsHumansMiceNerve Tissue ProteinsAtaxin-1AtaxinsATXN1 protein, humanAtxn1 protein, mouseAtxn1 protein, ratCALB1 protein, humanCalb1 protein, mouseCalb1 protein, ratCalbindin 1CalbindinsCross-Linking ReagentsGreen Fluorescent ProteinsGTP-Binding ProteinsNerve Tissue ProteinsNuclear ProteinsPeptidespolyglutamineProtein Glutamine gamma Glutamyltransferase 2S100 Calcium Binding Protein GTGM2 protein, humanTgm2 protein, ratTransglutaminases

Identifiers

PMID17442486
PMCPMC1949022
OpenAlexW1964232673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.